800 related articles for article (PubMed ID: 8543829)
1. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
Miletic VD; Hester CG; Frank MM
J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
[TBL] [Abstract][Full Text] [Related]
2. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
Schreiber AD; Frank MM
J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
[TBL] [Abstract][Full Text] [Related]
3. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
4. Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation.
Pluschke G; Bordmann G; Daoudaki ME; Lambris JD; Achtman M; Neibert M
Eur J Immunol; 1989 Jan; 19(1):131-5. PubMed ID: 2646134
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of immune precipitation by complement.
Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
[TBL] [Abstract][Full Text] [Related]
6. C4 does not bind to human and rabbit IgM during activation of the classical complement pathway on the red cell.
Circolo A; Borsos T
J Immunol; 1982 Oct; 129(4):1485-8. PubMed ID: 7108214
[TBL] [Abstract][Full Text] [Related]
7. Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.
Füst G; Medgyesi GA; Rajnavölgyi E; Csécsi-Nagy M; Czikora K; Gergely J
Immunology; 1978 Dec; 35(6):873-84. PubMed ID: 104923
[TBL] [Abstract][Full Text] [Related]
8. Antibody--antigen complex stimulated lysis of non-sensitized sheep red cells by human lymphocytes. I. Requirements for IgG complexes.
Fuson EW; Shaw MW; Hubbard RA; Lamon EW
Clin Exp Immunol; 1979 Oct; 38(1):158-65. PubMed ID: 316751
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation.
Russell MW; Reinholdt J; Kilian M
Eur J Immunol; 1989 Dec; 19(12):2243-9. PubMed ID: 2606139
[TBL] [Abstract][Full Text] [Related]
10. Activation of effector functions by immune complexes of mouse IgG2a with isotype-specific autoantibodies.
Rajnavölgyi E; Fazekas G; Lund J; Daeron M; Teillaud JL; Jefferis R; Fridman WH; Gergely J
Immunology; 1995 Apr; 84(4):645-52. PubMed ID: 7540592
[TBL] [Abstract][Full Text] [Related]
11. Complement fixation by rheumatoid factor.
Tanimoto K; Cooper NR; Johnson JS; Vaughan JH
J Clin Invest; 1975 Mar; 55(3):437-45. PubMed ID: 1078825
[TBL] [Abstract][Full Text] [Related]
12. Complement and sepsis.
Gutiérrez-Fernández J; Maroto MC; Piédrola G; Zamora E
Allergol Immunopathol (Madr); 1987; 15(3):145-9. PubMed ID: 3661354
[TBL] [Abstract][Full Text] [Related]
13. C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.
Garred P; Michaelsen TE; Aase A; Mollnes TE
J Immunol; 1990 Jan; 144(1):198-203. PubMed ID: 2295791
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation.
Rieben R; Roos A; Muizert Y; Tinguely C; Gerritsen AF; Daha MR
Blood; 1999 Feb; 93(3):942-51. PubMed ID: 9920844
[TBL] [Abstract][Full Text] [Related]
15. The immunoglobulin and complement levels in the active pulmonary sarcoidosis.
Cagatay T; Bilir M; Gulbaran M; Papila C; Cagatay P
Kobe J Med Sci; 2003; 49(5-6):99-106. PubMed ID: 15141145
[TBL] [Abstract][Full Text] [Related]
16. The significance of immunofluorescent immunoglobulin inclusions in polymorphonuclear leucocytes for the detection of circulating immune complexes.
Kauffmann RH; de Rooy-Dijk HH; Klein F; Lafeber GJ; Cats A; van Es LA
Clin Exp Immunol; 1983 Oct; 54(1):203-12. PubMed ID: 6311469
[TBL] [Abstract][Full Text] [Related]
17. The activation of C3 and C4 in human serum by immune complexes containing mouse monoclonal antibodies of different isotype and affinity: effects on solubilisation.
Stewart WW; Johnson A; Steward MW; Whaley K; Kerr MA
Mol Immunol; 1988 Dec; 25(12):1355-61. PubMed ID: 3266294
[TBL] [Abstract][Full Text] [Related]
18. Anti-immunoglobulin autoantibodies are not preferentially induced in polyclonal activation of human and mouse lymphocytes, and more anti-DNA and anti-erythrocyte autoantibodies are induced in polyclonal activation of mouse than human lymphocytes.
Dziarski R
J Immunol; 1984 Nov; 133(5):2537-44. PubMed ID: 6207235
[TBL] [Abstract][Full Text] [Related]
19. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
Lucisano Valim YM; Lachmann PJ
Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
[TBL] [Abstract][Full Text] [Related]
20. Activation of rat complement by soluble and insoluble rat IgA immune complexes.
Rits M; Hiemstra PS; Bazin H; Van Es LA; Vaerman JP; Daha MR
Eur J Immunol; 1988 Dec; 18(12):1873-80. PubMed ID: 3220102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
